Announcing: 2026 Signals that Move Us Image Competition Winners
Research often uncovers incredible visual beauty alongside data and discovery.
This year, our community highlighted that intersection through the Signals That Move Us
Image Competition. We received 12 entries from our trainees, each offering a unique look at the signals, structures, and cellular dynamics driving our research. With so many strong entries, selecting the top spots was a difficult task for the committee. We want to extend a sincere thank you to everyone who took the time to submit their work and share their microscopy and scientific
imaging with the community.
Meet the Winners
1st Place: Madison Garibotti
PhD Candidate, York University
Supervised by Dr. Christopher Perry
Image Title: You Can Find Happiness in the Oddest Places!
2nd Place: Dr. Tatiana Koike
Postdoctoral Research Fellow, CHU Sainte Justine and Université de Montréal
Supervised by Dr. Nicolas Dumont
Image Title: The Neuromuscular Junction as a Living Rose
3rd Place: Alexa Derksen
PhD Candidate, University of Ottawa and CHEO Research Institute
Supervised by Dr. Hanns Lochmuller
Image Title: 3D iPSC derived Neuromuscular Organoid
Image Competition Art Gallery now live!
In addition to the top three winners, we received many outstanding submissions from neuromuscular trainees across Canada. The full exhibition is now live. Our online art gallery showcases all 12 submitted images, including the top three, featuring work that ranges from cellular staining to complex structural patterns.
Explore the Art Gallery
Planning for Next Year competition
To all of our trainees: as you collect your data over the coming months, keep an eye out for
striking visuals. Whether you are working with confocal microscopy, western blots, or
computational models, we encourage you to save your best shots. We look forward to seeing your submissions for next year’s competition. Congratulations again to our winners, and thank you to everyone who participated.
Read next...
New Publication from the NMD4C Clinical Trial Network Strengthens Trial Capacity in Canada
We are pleased to share a new publication from the NMD4C Clinical Trial Network led by Kerri Lynn Schellenberg, Homira Osman, Maria Masnata, Rhiannon Hicks, Corinne Kagan, Ana Stosic, Stacey Lintern, Erin Beattie, Drs. Hanns Lochmüller, Craig Campbell, and Jean K Mah. This work focuses on the implementation of a coordinated Canadian neuromuscular clinical trial network to enhance trial readiness, capacity, and access in rare disease research.
Canadian-Led Phase II Studies Advance Vamorolone Evidence in Duchenne Muscular Dystrophy
NMD4C investigators contributed to two phase II studies evaluating vamorolone in boys with Duchenne muscular dystrophy across early childhood and adolescence, demonstrating safety, favorable pharmacokinetics, and potential efficacy. Led by Dr. Jean Mah and conducted across Canadian clinical trial sites with national and industry collaborators, the findings supported Health Canada approval of vamorolone as the first treatment for DMD in Canada. Leaders from both the clinical and patient advocacy communities, including Defeat Duchenne Canada, highlighted the impact of collaboration among patients, families, clinicians, and researchers in advancing care and improving access to new therapies.
Advancing AFC in Neuromuscular Medicine: Program Launch & September Workshop
The Royal College has approved National Training Standards for the AFC in Neuromuscular Medicine, creating a formal pathway to recognize enhanced competence with the DRCPSC credential. This designation establishes a national training standard, supports portable certification, and strengthens clinical capacity across Canada. PGME offices can now apply to offer accredited AFC programs, with a goal of five programs submitting applications by the end of 2026.